These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 7258274

  • 1. Glucocorticosteroid inhibition of intraocular proliferation.
    Weiss JF, Belkin M.
    Am J Ophthalmol; 1981 Jul; 92(1):133. PubMed ID: 7258274
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Intravitreal injection of triamcinolone acetonide for diabetic macular edema.
    Kuhn F, Barker D.
    Arch Ophthalmol; 2004 Jul; 122(7):1082-3; author reply 1086-8. PubMed ID: 15249385
    [No Abstract] [Full Text] [Related]

  • 5. Intravitreal triamcinolone acetonide for exudative age related macular degeneration.
    Wong D, Campbell I, Groenwald C, Lancaster E.
    Br J Ophthalmol; 2004 Apr; 88(4):598; author reply 598. PubMed ID: 15031200
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Intravitreal triamcinolone acetonide as treatment for extensive exudative retinal detachment.
    Jonas JB.
    Br J Ophthalmol; 2004 Apr; 88(4):587-8. PubMed ID: 15031187
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Persistent depot of triamcinolone acetonide after a single intravitreal injection.
    Vedantham V, Kolluru C, Ramasamy K.
    Indian J Ophthalmol; 2005 Mar; 53(1):65-6. PubMed ID: 15829753
    [Abstract] [Full Text] [Related]

  • 14. Diffuse diabetic macular oedema treated with intravitreal bevacizumab or triamcinolone acetonide.
    Rensch F, Spandau UH, Wickenhäuser A, Jonas JB.
    Acta Ophthalmol; 2010 Mar; 88(2):e36-7. PubMed ID: 19210330
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Intravitreal triamcinolone acetonide in serpiginous choroidopathy.
    Pathengay A.
    Indian J Ophthalmol; 2005 Mar; 53(1):77-9. PubMed ID: 15829756
    [No Abstract] [Full Text] [Related]

  • 17. Finer points about intravitreal corticosteroids.
    Vedantham V.
    Indian J Ophthalmol; 2003 Sep; 51(3):285; author reply 285-6. PubMed ID: 14601865
    [No Abstract] [Full Text] [Related]

  • 18. Chronic prephthisical ocular hypotony treated by intravitreal triamcinolone acetonide.
    Jonas JB, Vossmerbaeumer U, Kamppeter BA.
    Acta Ophthalmol Scand; 2004 Oct; 82(5):637. PubMed ID: 15453876
    [No Abstract] [Full Text] [Related]

  • 19. Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema.
    Jonas JB, Degenring RF, Kamppeter BA, Kreissig I, Akkoyun I.
    Am J Ophthalmol; 2004 Jul; 138(1):158-60. PubMed ID: 15234306
    [Abstract] [Full Text] [Related]

  • 20. Intraocular concentration of triamcinolone acetonide after intravitreal injection in the rabbit eye.
    Kamppeter BA, Cej A, Jonas JB.
    Ophthalmology; 2008 Aug; 115(8):1372-5. PubMed ID: 18355920
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.